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Objectives: This study aimed to identify the prevalences of and risk factors associated with the
development of gallbladder stones and polyps in a large Chinese population.
Methods: Prevalences of and risk factors for biliary stones and gallbladder polyps were retrospectively
investigated among subjects who underwent a general check-up at the Health Screening Centres of
Peking Union Medical College Hospital and Beijing Charity Hospital between January 2007 and June
2010.
Results: A total of 60 064 people were enrolled in the study. Overall prevalences of biliary stones and
gallbladder polyps were 4.2% (n = 2527) and 6.9% (n = 4119), respectively. Risk factors associated with
increased odds ratios (ORs) for the development of biliary stones were female gender (OR = 1.51), age
50 years (OR = 2.09), history of hypertension (OR = 1.37), thickened gallbladder wall (cholecystitis)
(OR = 1.98), fasting blood glucose 6.10 mmol/l (OR = 1.27), body mass index 25 kg/m2 (OR = 1.25),
systolic blood pressure 140 mmHg (OR = 1.31) and diastolic blood pressure 90 mmHg (OR = 1.44).
Factors associated with gallbladder polyps were female gender (OR = 0.66), thickened gallbladder wall
(OR = 2.09), negativity for hepatitis B surface antigen (HBsAg) and positivity for hepatitis B core antibody
(anti-HBc) (OR = 2.61), and positivity for both HBsAg and anti-HBc (OR = 3.21).
Conclusions: Prevalences of biliary stones and gallbladder polyps among Chinese people are similar to
those reported for other populations. Biliary stones appear to be associated with female gender, age,
obesity, blood glucose, blood pressure and cholecystitis. Male gender, hepatitis B virus infection and
cholecystitis were strong risk factors for the formation of gallbladder polyps.
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Introduction
Biliary stones (including stones in the gallbladder and/or bile
ducts) and gallbladder polyps are the most common biliary dis-
eases and are important public health problems in many countries
and significant causes of morbidity in the Chinese population.1–6
Strategies aimed at reducing the incidence of biliary stones and
gallbladder polyps would be deemed beneficial. In population
studies, biliary stones and gallbladder polyps can be easily diag-
nosed by abdominal ultrasonography (US) with high sensitivity
(>92%) and specificity (>95%). As a result, abdominal US
has become widely used during routine check-ups in the general
public.4,7,8
Hyperlipidaemia is generally characterized by high serum levels
of total cholesterol (TC), triglycerides (Tri), low-density lipopro-
tein (LDL), and a low level of high-density lipoprotein (HDL),*These authors contributed equally to this study.
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all of which have been associated with gallstones.4,9–11 Given the
relationship between hyperlipidaemia and biliary stones, and the
strong link between biliary stones and gallbladder polyps, it is
plausible that serum lipids, particularly hyperlipidaemia, may be
associated with gallbladder polyps.
A thickened gallbladder wall (TGW) is thought to be a
major clinical manifestation of cholecystitis.12 Few studies have
addressed the relationship between asymptomatic TGW and
gallbladder diseases.
Hepatitis B virus (HBV) infection is endemic in China.13 A
recent case–control study carried out in China suggested that
HBV infection is a strong risk factor for the development of gall-
bladder polyps.4 However, the study did not differentiate between
subjects who were negative for hepatitis B surface antigen
(HBsAg) and negative for hepatitis B core antibody (anti-HBc)
and those who were negative for HBsAg and positive for anti-HBc.
Many previous studies have shown that the risk factors associ-
ated with biliary stones are age, race, gender, obesity and diabetes
mellitus; and that those associated with gallbladder polyps are age,
gender, body mass index (BMI), HBV infection and diabetes
mellitus.4,5,14–16 However, in China, prevalences of biliary stones
and gallbladder polyps are seldom reported and the risk factors
for these conditions are incompletely defined,2,4,14,17 especially in
terms of associations between hyperlipidaemia, TGW and hepa-
titis B status, and gallbladder polyps. A clearer understanding of
prevalences and risk factors might improve strategies for the pre-
vention and treatment of biliary stones and gallbladder polyps.
Therefore, the aims of the current study were to identify the preva-
lences of and risk factors for biliary stones and gallbladder polyps
in a large Chinese population.
Materials and methods
Study population and design
This study was conducted at the Health Screening Centres of
Peking Union Medical College Hospital (PUMCH) and Beijing
Charity Hospital (BCH). These two hospitals provide medical
care for residents of Beijing and the surrounding metropolitan
areas. The sample population consisted of consecutive subjects
referred to the physical examination centre by their employers as
an annual requirement of their employment, and of individuals
who voluntarily attended a paid physical examination. A
structured data sheet was issued by the attending physician.
Body mass index (kg/m2) was used as a measure of obesity.
The recording of such data is routinely performed in both
institutions and data forms are kept as a component of health
examination reports.
Ultrasonography of the abdomen was conducted by ultra-
sonographers using a scanner equipped with a 3.5-MHz trans-
ducer (Philips Medical Systems, Inc., Bothell, WA, USA). In the
current study, US assessment was carried out after an overnight
fast. Subjects were asked to take up a supine position inclined to
the left and were scanned along the long axis or the horizontal axis
of the costal margins or between the ribs in order to obtain a clear
display of the gallbladder outline and internal echo, and to
observe the site, size, shape, number of internal lesions and echo
characteristics. Biliary stones were defined by the presence of
strong intraluminal echoes that were gravity-dependent or that
attenuated US transmission (acoustic shadowing) in the gallblad-
der, biliary ducts or both. The criterion for US diagnosis of a
gallbladder polyp was ‘hyperechoic immobile echoes protruding
from the gallbladder wall into the lumen without an acoustic
shadow’. This examination displayed the position, size and
number of gallbladder polyps and local changes in the gallbladder
wall. Thickening of the gallbladder wall was defined as a wall
thickness of >3 mm. Typically, it was associated with a layered
appearance.12 Historically, a TGW has been regarded as proof of
primary gallbladder disease and is a hallmark feature of acute and
chronic cholecystitis.12 As most of the participants in the current
study did not have related clinical symptoms, those with a TGW
were regarded as having asymptomatic cholecystitis. On the
completion of each patient’s participation in the study, all US
results were evaluated by experienced radiologists. In a second
evaluation, all studies for each participant were viewed side-by-
side in a masked fashion by the same radiologists. No discrepan-
cies were found between the results of the first and second
evaluations.
A manual retrospective review of the participants’ health
examination reports was performed to collect demographic, clini-
cal and risk factor information. This review examined demo-
graphic information and asked detailed questions on personal
medical history and medication intake. Age, gender, history of
hypertension and diabetes mellitus, weight, BMI, fasting blood
glucose (FBG), blood pressure, serum lipids, HBsAg and anti-HBc
data were abstracted. This study was performed after its protocol
had been approved by the ethics committees of both PUMCH and
BCH. Informed consent was obtained from all participants.
Laboratory tests
All study participants were subjected to overnight fasting after
which blood samples were drawn by venipuncture by clinical
nurses for laboratory examination. Fasting blood glucose, Tri, TC,
HDL and LDL were measured using a Hitachi Modular Analytics
System (Roche Modular DPP; Hitachi Ltd, Tokyo, Japan). The
presence of HBsAg and anti-HBc were tested using a second-
generation, enzyme-linked immunosorbent assay (Abbott Labo-
ratories, Inc., Chicago, IL, USA). Chronic HBV infection was
defined by the presence of both HBsAg and anti-HBc.
Statistical analysis
In order to make an appropriate case–control comparison, par-
ticipants with a history of cholecystectomy were excluded and
participants who tested negative for both biliary stones and gall-
bladder polyps were recognized as controls. Distributions of
selected characteristics were evaluated among cases and controls.
Subjects with both gallbladder polyps and biliary stones were
counted in both groups. The Mann–Whitney U-test was used to
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test differences in characteristics between the groups. A P-value of
<0.05 was considered to indicate statistical significance.Univariate
analysis results are expressed as odds ratios (ORs) and 95% con-
fidence intervals (CIs). To evaluate potential risk factors associated
with biliary stones and gallbladder polyps, risk factors with
P-values of <0.05 were added to multivariate logistic regression
models. Analyses were carried out using spss Version 13.0 (SPSS,
Inc., Chicago, IL, USA).
Results
The Informatics databases at PUMCH and BCH were used to
compile a list of all visitors to the two institutions between
January 2007 and June 2010. During that time, 101 411 visitors
were recorded, 61 252 (60.4%) of whom underwent US, physical
examination and related blood tests. A total of 202 participants
(0.3%), including seven with biliary stones, 23 with gallbladder
polyps and 172 controls who tested positive for HBsAg but
negative for anti-HBc were excluded from analysis because
it was not possible to determine whether they had a chronic
HBV infection, an acute HBV infection or a false positive HBsAg
result. A further 986 (1.6%) subjects who had previously under-
gone cholecystectomy were excluded, leaving 60 064 (59.2%) par-
ticipants for further analysis. Their median age was 44 years
(range: 14–95 years) and 32 380 (53.9%) were male. Among the
60 064 subjects, 44 193 (73.6%) were Beijing residents, 8975
(14.9%) were from Hebei and 4801 (8.0%) were from Shandong;
the remaining 2095 (3.5%) people were from other cities. The
overall prevalences of biliary stones, gallbladder polyps and TGW
in this study were 4.2% (2527/60 064), 6.9% (4119/60 064) and
9.2% (5537/60 064), respectively. A total of 151 (0.25%) subjects
had both biliary stones and gallbladder polyps. Uni- and multi-
variate analyses of risk factors for both groups are shown in
Tables 1 and 2.
Figure 1 displays age-stratified prevalences of the gallbladder
diseases. Prevalences of biliary stones and TGW increased with
age, whereas gallbladder polyps were more common in middle-
aged subjects and peaked in people aged 41–50 years. Figure 2
displays age-stratified prevalences of biliary stones in male and
female subjects. Prevalences of biliary stones were higher in female
than in male participants in all age groups. Overall, female sub-
jects had a significantly higher prevalence of biliary stones com-
pared with male subjects [4.5% (1237/27 684) vs. 4.0% (1290/
32 380); P = 0.036]. Figure 3 displays age-stratified prevalences of
gallbladder polyps in male and female participants. Prevalences of
gallbladder polyps were higher in male than in female subjects in
all age groups (except in participants aged >70 years). By contrast
with prevalences of biliary stones, the prevalence of gallbladder
polyps was significantly higher in male than in female subjects
[8.3% (2685/32 380) vs. 5.2% (1434/27 684); P < 0.001]. Similar
to gallbladder polyps, the prevalence of a TGWwas higher in male
than in female subjects in all age groups [13.9% (4498/32 380) vs.
3.8% (11 038/27 684); P < 0.001] (Fig. 4).
Discussion
This is the first and largest retrospective cohort study to evaluate
the prevalences of and risk factors for biliary stones and
gallbladder polyps in the Chinese population. The prevalence of
biliary stones in this study (4.2%) is similar to those found in
previous sonographic screening studies conducted in China,
Japan and Korea, where biliary stones were identified in 4.2–11%
of the population.2,14,17–23 The current study demonstrated a
higher prevalence of biliary stones in females than in males in all
age groups and showed that prevalence increased with age,
which is in agreement with previous research.4 The common
perception that women are at greater risk for developing biliary
stones than men largely reflects extraneous risk factors, such
as pregnancy and sex hormones. Oestrogen increases biliary
cholesterol secretion, causing cholesterol supersaturation of bile.
Thus, hormone replacement therapy in postmenopausal women
has been associated with an increased risk for developing biliary
stones.24,25
The current study also confirmed a prevalence (6.9%) of gall-
bladder polyps in the Chinese population lower than that previ-
ously reported in Taiwan (9.5%),4 but higher than those reported
in Danish (4.3%),26 Japanese (5.6%)27,28 and German (6.1%)15
populations. This study demonstrated a higher prevalence of gall-
bladder polyps in male than in female subjects in all age groups
(except in people aged >70 years), which is consistent with find-
ings in some studies,5,14,29,30 but contrary to those in others.31,32 Yet
other studies have reported no differences in prevalence between
the sexes.26,33
The prevalence of gallbladder polyps was higher than that of
biliary stones in participants aged >60 years in this study. This
finding is comparable with Lin et al.’s observation that gallbladder
polyps were prevalent in middle-aged subjects.4 The reason for the
diminishing prevalence of gallbladder polyps with age is not clear.
Unlike Lin et al., who believed that this apparent decrease in gall-
bladder polyps may emerge because the increase in biliary stones
with age masks the presence of gallbladder polyps during sonog-
raphy,4 the present authors believe that agemay not be a risk factor
for gallbladder polyps. Logistic regression also failed to find an
association between age and gallbladder polyps in the current
study.
Although univariate regression in this study indicated that
metabolic diseases (high levels of TC, Tri and LDL, and low HDL)
were statistically related to the presence of biliary stones, multi-
variate logistic regression analysis failed to demonstrate any
association. The current results are contrary to those of several
previous studies,11,34 but in agreement with others.34,35 Reasons for
the inconsistencies across studies are unclear, but may reflect dif-
ferences in study design, study populations, lipid measurement
methods, or inadequate control for confounding. The same
factors may also explain the univariate association between biliary
stones and fatty liver, for which no association emerged during
multivariate regression analysis.
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Although a history of diabetes is not associated with biliary
stones, FBG shows a strong relationship with their occurrence. A
further analysis identified that rates of high FBG among subjects
with biliary stones were lower in subjects with a history of dia-
betes (73.9%, 178/241) than in healthy controls (77.2%, 1734/
2245). These results suggest that blood glucose, rather than a
history of diabetes, contributes to the formation of biliary stones,
and people with diabetes may lower their risk for biliary stones
by controlling their blood glucose level. This finding is in agree-
ment with those of several other population-based studies.8–10
The underlying mechanism of the relationship between blood
glucose and biliary stones may be fasting hyperinsulinaemia,
Table 2 Mean level of different characteristics for gallbladder diseases
Controls Subjects with biliary stones Subjects with gallbladder polyps
Median (range) Median (range) P-valuea Median (range) P-valuea
Age, years 43 (14–95) 53 (20–89) 0.000 44 (18–84) 0.009
Weight, kg 66.8 (32.0–158.0) 69.0 (36.0–145.6) 0.127 68.5 (39.0–116.0) 0.430
SBP, mmHg 121 (79–217) 127 (86–189) 0.000 120 (83–208) 0.285
DBP, mmHg 75 (40–148) 77 (46–129) 0.000 76 (47–133) 0.038
FBG, mmol/l 4.9 (2.1–20.6) 5.1 (3.4–19.6) 0.000 4.9 (3.0–18.1) 0.049
TC, mmol/l 4.86 (1.16–14.69) 5.00 (2.40–10.18) 0.000 4.91 (1.94–9.01) 0.503
Tri, mmol/l 1.23 (0.18–43.10) 1.41 (0.28–25.88) 0.000 1.23 (0.23–29.68) 0.304
HDL, mmol/l 1.31 (0.33–3.74) 1.27 (0.50–3.13) 0.000 1.30 (0.54–2.97) 0.001
LDL, mmol/l 3.02 (0.38–9.57) 3.18 (0.90–8.35) 0.000 3.06 (0.80–6.69) 0.004
BMI, kg/m2 23.53 (12.67–57.32) 25.40 (15.97–44.25) 0.006 24.28 (16.23–49.67) 0.580
aMann–Whitney test.
Compared with controls, subjects with biliary stones had significantly higher mean levels of age, SBP, DBP, FBG, TC, Tri, LDL, BMI and a lower mean
level of HDL. Subjects with gallbladder polyps had significantly higher levels of age, DBP, FBG and LDL, and a lower level of HDL.
SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TC, total cholesterol; Tri, triglyceride; HDL, high-density
lipoprotein; LDL, low-density lipoprotein; BMI, body mass index.
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Figure 1 Prevalences of gallbladder diseases in different age groups in Chinese subjects. Prevalences of biliary stones and diseased cystic
wall increased with age, whereas gallbladder polyps were more common in middle age, peaking in subjects aged 41–50 years. GB polyps,
gallbladder polyps; B stones, biliary stones; TGW, thickened gallbladder wall
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Figure 2 Prevalences of gallstones stratified by gender in different age groups in Chinese subjects. Prevalences of biliary stones were higher
in female than in male subjects in all age groups
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Figure 3 Prevalences of gallbladder polyps stratified by gender in different age groups in Chinese subjects. Prevalences of polyps were
higher in male than in female subjects in all age groups (except in subjects aged >70 years)
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which can overactivate the rate-limiting enzyme for cholesterol
synthesis36 and ultimately lead to cholesterol saturation in the
bile. Reduced motility of the gallbladder in persons with diabetes
is another possible explanation.37,38
In the current study, obesity was significantly associated with
biliary stones. Previous studies have been discrepant in findings
pertaining to BMI and biliary stones.39,40 This discrepancy has not
been fully explained. Themechanism responsible for the increased
risk for biliary stones in obese persons may involve an increase in
bile saturation that results from an increasing biliary secretion of
cholesterol, which is likely to depend on a higher rate of synthesis
of cholesterol in obese persons.41
The current study also found that a history of hypertension,
and high systolic and diastolic blood pressure may be risk factors
for biliary stones, which is consistent with findings in a previous
study.42 Given the strong association between biliary stones and
metabolic syndrome (obesity and high level of blood glucose)
identified in this study, an association between blood pressure
and metabolic syndrome and biliary stones appears logical. In
view of greater insulin resistance and higher levels of plasma
insulin, this association may be explained by the action of insulin
in hypertension.
Infection with HBV is endemic in China and the HBsAg posi-
tive rate in the general population is high (9.09%).13 The current
study found a strong association between HBV infection and gall-
bladder polyps. A strong association between anti-HBc (without
HBsAg) and gallbladder polyps was also found in this study;
however, whether anti-HBc reflects other unmeasured exposures
or subclinical HBV infection is not clear. It has been suggested that
anti-HBc may be the only positive marker of HBV in cases with
chronic infection, especially if the exposure occurred a long time
previously and the HBsAg titres have dropped below critical levels
for detection.43 The present results are in agreement with those of
another study in an ethnic Chinese population, conducted by Lin
et al.,4 but contrary to those of Chen et al.5 The differences in
findings may be explained by the fewer subjects and lower per-
centage of males and HBV carriers in the study by Chen et al.5
Hepatitis B viral infection can result in chronic liver disease and
US changes to the liver.44–46 In acute HBV infection, the gallblad-
der also undergoes abnormal changes, such as wall thickening,
luminal abnormality and alterations in volume.47 HBsAg can be
found in the bile of subjects with acute HBV infection.48 However,
the pathophysiology of the association between gallbladder polyps
and HBV remains unknown. According to the analytical data in
this study, chronic HBV infection was associated with gallbladder
polyp development.
A TGW was considered a marker of cholecystitis. In line with
the generally accepted association between a TGW and gallblad-
der polyps, the present authors observed that a TGW was
associated with both biliary stones and gallbladder polyps
independently of the other lipids and risk factors examined. This
may be because the dysfunction of cholecystitis contributes to the
development of biliary stones and gallbladder polyps.
Although relationships between gallbladder polyps and hyper-
lipidaemia,diabetes and obesity have been established previously,29
this study did not identify associations between those risk factors
and gallbladder polyps. The present authors believe that metabolic
syndrome does not contribute to the formation of gallbladder
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Figure 4 Prevalences of a thickened gallbladder wall stratified by gender in different age groups in Chinese subjects. Prevalences of a
diseased cystic wall were higher in male than in female subjects in all age groups
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polyps, although this is contrary to the findings of a previous
report.29 It is the authors’ belief that, rather than systemic factors,
local factors such as local inflammation (cholecystitis and HBV
infection) play a key role in the formation of gallbladder polyps.
The diagnosis of biliary disease in the current study was based
on US rather than pathology and therefore potential for misdiag-
nosis exists. However, US has been shown to be highly specific for
biliary disease.49 In addition, the radiologists who evaluated the
US results were very experienced and all films were read twice. In
addition, the detailed behavioural and epidemiological data were
prospectively and systematically collected.
In China, abdominal US is routinely incorporated into the
physical examination. To avoid bias within the current study, sub-
jects who were paying for the routine examination and selected to
undergo only a partial assessment were excluded from this study
and thus a full dataset was obtained. In addition, almost all sub-
jects were asymptomatic as this assessment was derived from the
results of routine medical assessments driven by various sources.
Thus, it would seem unlikely that this study excluded a subgroup
of subjects with different risk factors and it is probable that this
sample represents a true picture of the population studied.
Although the current study was based in only two institutions,
its subjects originated from multiple Chinese cities in large
numbers and hence would seem to constitute a reasonable repre-
sentation of the Chinese population. Furthermore, Beijing is one
of the most international cities in China and the lifestyle of its
residents is largely Westernized; therefore, the findings of the
current study may also be meaningful for the populations of
Westernized cities around the world.
In conclusion, this study demonstrated biliary stones and gall-
bladder polyps in 4.2% and 6.9%, respectively, of a Chinese study
population and indicated that cholecystitis may be present in
9.2%. Female gender, increased age, obesity, increased blood
glucose, high blood pressure and cholecystitis were independent
risk factors for the development of biliary stones. Male gender,
HBV infection and cholecystitis were independent risk factors for
the formation of gallbladder polyps.
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